A
B
Walavalkar K, Notani D.
2020. Beyond the coding genome: non-coding mutations and cancer.. Front Biosci (Landmark Ed). 25:1828-1838.
C
E
Venkatesan V, Christopher ACrystal, Rhiel M, Azhagiri MKumar K, Babu P, Walavalkar K, Saravanan B, Andrieux G, Rangaraj S, Srinivasan S et al..
2023. Editing the core region in HPFH deletions alters fetal and adult globin expression for treatment of β-hemoglobinopathies.. Mol Ther Nucleic Acids. 32:671-688.
F
Notani D.
2022. First glimpse of enhancers in gene regulation.. Nat Rev Genet.
I
L
Saravanan B, Soota D, Islam Z, Majumdar S, Mann R, Meel S, Farooq U, Walavalkar K, Gayen S, Singh AKumar et al..
2020. Ligand dependent gene regulation by transient ERα clustered enhancers.. PLoS Genet. 16(1):e1008516.
O
Farooq U, Notani D.
2021. Optimized protocol to create deletion in adherent cell lines using CRISPR/Cas9 system.. STAR Protoc. 2(4):100857.
R
Walavalkar K, Saravanan B, Singh AKumar, Jayani RSingh, Nair A, Farooq U, Islam Z, Soota D, Mann R, Shivaprasad PV et al..
2020. A rare variant of African ancestry activates 8q24 lncRNA hub by modulating cancer associated enhancer.. Nat Commun. 11(1):3598.
S
T
Blobel GA, Higgs DR, Mitchell JA, Notani D, Young RA.
2021. Testing the super-enhancer concept.. Nat Rev Genet.
Mann R, Notani D.
2023. Transcription factor condensates and signaling driven transcription.. Nucleus. 14(1):2205758.
Farooq U, Notani D.
2022. Transcriptional regulation of INK4/ARF locus by cis and trans mechanisms.. Front Cell Dev Biol. 10:948351.
U
Adhikari S, Singh V, Nandi S, Ghosal M, Raj NSundar, Khanna J, Bhattacharya A, Kabiraj A, Mondal A, Vasudevan M et al..
2024. UBR7 in concert with EZH2 inhibits the TGF-β signaling leading to extracellular matrix remodeling.. Cell Rep. 43(7):114394.